Shopping Cart
Remove All
Your shopping cart is currently empty
Telisotuzumab(ABT-700) is a humanized recombinant antibody targeting the therapeutic hepatocyte growth factor receptor (MET) with high affinity for c-Met.Telisotuzumab has inhibitory effects on c-Met signaling and antitumor activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $372 | - | In Stock | |
| 5 mg | $933 | Backorder | Backorder | |
| 10 mg | $1,490 | Backorder | Backorder | |
| 25 mg | $2,190 | Backorder | Backorder | |
| 50 mg | $2,970 | Backorder | Backorder | |
| 100 mg | $3,930 | Backorder | Backorder |
| Description | Telisotuzumab(ABT-700) is a humanized recombinant antibody targeting the therapeutic hepatocyte growth factor receptor (MET) with high affinity for c-Met.Telisotuzumab has inhibitory effects on c-Met signaling and antitumor activity. |
| In vitro | Telisotuzumab (ABT-700) (10 μg/mL; 24 h) inhibits SNU5 cell proliferation, increases pro-apoptotic Bim, decreases anti-apoptotic Bcl-xL, and induces apoptosis.[1] |
| In vivo | Telisotuzumab (ABT-700) (2.5-40 mg/kg; i.p.; twice a week; 90 days) potently antagonizes constitutively activated c-Met and downstream signaling, thereby inhibiting tumor growth in Hs746T cell-derived SCID mice.[1] |
| Synonyms | Mab-224G11, ABT-700 |
| Molecular Weight | 145.50 kDa |
| Cas No. | 1781223-80-0 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.